Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barbui

Showing results (31-40 of 380) with videos related to

Pageof 38
Sort By:
Clinical Chemistry|May 26, 2001
Prevalence of different anti-phospholipid antibodies in systemic lupus erythematosus and their relationship with the antiphospholipid syndromeM Galli, T Barbui
Seminars in Hematology|February 4, 1999
Clinical parameters for determining when and when not to treat essential thrombocythemiaT Barbui, G Finazzi
Hematology (Amsterdam, Netherlands)|July 14, 2016
The Management of Polycythaemia VeraT C Pearson, T Barbui
Thrombosis and Haemostasis|December 18, 1987
Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 casesG Finazzi, R Caccia, T Barbui
Minerva Anestesiologica|April 17, 1999
[Management of quantitative and qualitative platelet defects]T Barbui, G Finazzi, M Galli
Thrombosis and Haemostasis|March 1, 1996
Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndromeM Galli, A Grassi, T Barbui
British Journal of Haematology|April 1, 1996
Thrombocytopenia in the antiphospholipid syndromeM Galli, G Finazzi, T Barbui
Leukemia|May 1, 1995
Institutional performance and dose intensity as prognostic factors in adult ALLR Bassan, T Lerede, T Barbui
Thrombosis and Haemostasis|July 29, 1984
Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?P Viero, S Cortelazzo, T Barbui
Thrombosis and Haemostasis|July 1, 1995
Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodologyT Barbui, G Finazzi, A Remuzzi
Pageof 38

Showing results (31-40 of 380) with videos related to

Sort By:
Pageof 38
Clinical Chemistry|May 26, 2001
Prevalence of different anti-phospholipid antibodies in systemic lupus erythematosus and their relationship with the antiphospholipid syndromeM Galli, T Barbui
Seminars in Hematology|February 4, 1999
Clinical parameters for determining when and when not to treat essential thrombocythemiaT Barbui, G Finazzi
Hematology (Amsterdam, Netherlands)|July 14, 2016
The Management of Polycythaemia VeraT C Pearson, T Barbui
Thrombosis and Haemostasis|December 18, 1987
Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 casesG Finazzi, R Caccia, T Barbui
Minerva Anestesiologica|April 17, 1999
[Management of quantitative and qualitative platelet defects]T Barbui, G Finazzi, M Galli
Thrombosis and Haemostasis|March 1, 1996
Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndromeM Galli, A Grassi, T Barbui
British Journal of Haematology|April 1, 1996
Thrombocytopenia in the antiphospholipid syndromeM Galli, G Finazzi, T Barbui
Leukemia|May 1, 1995
Institutional performance and dose intensity as prognostic factors in adult ALLR Bassan, T Lerede, T Barbui
Thrombosis and Haemostasis|July 29, 1984
Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?P Viero, S Cortelazzo, T Barbui
Thrombosis and Haemostasis|July 1, 1995
Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodologyT Barbui, G Finazzi, A Remuzzi
Pageof 38